Current treatment guidelines include surgical excision, local ablation, intralesional therapy, and regional chemotherapy, along with targeted drugs (e.g., against the V600E BRAF mutation).7 There are currently few drug therapies, especially for BRAF wild-type patients, that can provide rapid, sustained reduction of tumor burden with low toxicity. This evidence concerns the gene BRAF and neoplasm.